Jeremy Sokolove reports tax withholding on shares at VOR
By AlphaYouPublished Form 4
Sokolove Jeremy Brett
Reporting filer
Jeremy Brett Sokolove reports tax withholding on shares, not an open-market purchase or sale, in Vor Biopharma Inc.. Form 4 filed Nov 5, 2026 lists 1 entry.
- Disclosed
- Nov 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sokolove Jeremy Brett | 2026-11-02 | F | Tax/exercise withholding | 1917 | 19.25 | 25,983 | 3 days | Filed terms
|
Common Stock
- Owner
- Sokolove Jeremy Brett
- Date
- 2026-11-02
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 1917
- Price
- 19.25
- Following holdings
- 25,983
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: false
- id: F1
- transaction Shares: 1917
- transaction Price Per Share: 19.25
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 25983
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sokolove Jeremy Brett: Chief Medical Officer.
- F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 1, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.